Fierce Pharma
OCTOBER 6, 2023
While the White House recently touted the FDA’s efforts to mitigate the ongoin | The National Comprehensive Cancer Network found that 72% of centers are still experiencing a carboplatin shortage, while 59% remain low on cisplatin. The survey follows a June report which found that nearly all centers had short supply of the chemotherapies.
MedCity News
OCTOBER 6, 2023
The digital health sector’s quarterly investment trends seem to be stabilizing in 2023, according to a new report from Rock Health. The report noted investors are shifting their focus away from pandemic-era categories like telehealth and pharmaceutical R&D catalysts — instead, they’re interested in startups creating products for disease treatment, the improvement of nonclinical workflows and the enablement of value-based care.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
OCTOBER 6, 2023
Amgen has completed its $27.8 billion acquisition of Horizon Therapeutics after fending off a legal challenge by the U.S. antitrust watchdog. | Amgen has completed its $27.8 billion acquisition of Horizon Therapeutics after fending off a legal challenge by the U.S. antitrust watchdog.
MedCity News
OCTOBER 6, 2023
The world is slowly aging, and by 2060, around 94.7 million older adults will be in the U.S. Without the proper care tactics in place, healthcare providers risk losing people at an earlier age and burning out family caregivers.
Fierce Pharma
OCTOBER 6, 2023
People who use Novo Nordisk’s popular weight-loss drugs are taking on a small risk of developing severe stomach problems, according to research conducted by the University of British Columbia and < | People who use Novo Nordisk’s popular weight-loss drugs are taking on a small risk of developing severe stomach problems, according to research conducted by the University of British Columbia.
MedCity News
OCTOBER 6, 2023
Propane can provide reassurance during this time of strain on the electric grid. It can keep hospitals and other critical facilities powered so that patients receive the care they need, and allow emergency responders to do their jobs effectively.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
OCTOBER 6, 2023
Precede Biosciences’ liquid biopsy platform yields insight into the genes and pathways in diseased tissue. Based on Dana-Farber Cancer Institute research, the startup aims to support biopharma drug R&D as it also develops the technology for clinical care applications.
European Pharmaceutical Review
OCTOBER 6, 2023
Positive interim results from Moderna’s Phase I/II trial of mRNA-1083 , an investigational vaccine designed to immunise against both influenza and COVID-19, have been released. There are several benefits of the combination vaccine as a preventative measure against these respiratory conditions, according to the pharmaceutical company. For example: higher patient compliance, easier administration and greater convenience.
MedCity News
OCTOBER 6, 2023
Ounce’s $5.2 million in seed funding was co-led by Meridian Street Capital and Flare Capital and included participation from Chelsea Clinton’s Metrodora Ventures, Wilshire Lane Capital, Hilton CEO Chris Nassetta and Unite Us Co-founder Taylor Justice.
Pharmaceutical Commerce
OCTOBER 6, 2023
Sr. Director of Community Engagement for Pharmaceuticals at GS1 US explains what the implementation guidelines are meant to accomplish.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
European Pharmaceutical Review
OCTOBER 6, 2023
The Indian Pharmacopoeia Commission (IPC) is now a member the Pharmacopoeial Discussion Group (PDG). As the Indian pharmaceutical industry is “a major manufacturer of the world’s medicines,” Jaap Venema, PhD, Executive Vice President and Chief Science Officer for USP declared, inclusion of the IPC in the discussion group is a “milestone” in expanding recognition of harmonised pharmacopoeial standards, Cathie Vielle, Secretary to the European Pharmacopoeia Commission added.
Pharmaceutical Commerce
OCTOBER 6, 2023
Conference hosts roundtable chats, with topics ranging from data-driven decision making to cold chain logistics.
Pharmaceutical Technology
OCTOBER 6, 2023
Ocular Therapeutix has confirmed the launch of a trial of an intravitreal eye implant intended to combat macular degeneration.
PharmaTimes
OCTOBER 6, 2023
The study used data from 50,000 people in the UK Biobank - News - PharmaTimes
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
PharmExec
OCTOBER 6, 2023
Lofaso discusses strategies that biotech companies can take once its time to make the big push.
PharmaTimes
OCTOBER 6, 2023
NPIP will transform medical research and provide better outcomes for patients - News - PharmaTimes
PharmExec
OCTOBER 6, 2023
Kalinovich previously worked at Wabtec as a corporate vice president.
pharmaphorum
OCTOBER 6, 2023
UK launches total-body PET drive to support drug discovery Phil.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
PharmaTech
OCTOBER 6, 2023
The BioIndustry Association reports that with a strong foundation in research and development in mRNA the United Kingdom will be a major player in this rapidly growing industry.
Scott’s Directories
OCTOBER 6, 2023
The Canadian healthcare sector, particularly the pharmacy industry, is massive and growing. With thousands of medical professionals, including general practitioners and specialists, the industry offers a rich ground for B2B ventures. Therefore, sales and marketing teams, data research groups, and pharmaceutical companies seeking to engage with this sector need more than just a list of pharmacies in Canada ; they require strategic approaches to connect and communicate with these professionals eff
Pharma Marketing Network
OCTOBER 6, 2023
Programmatic advertising is a modern form of digital media buying that has become increasingly popular with pharma marketers. It allows for precise targeting of potential customers, and is a great way to reach the right people with the right message. This article will provide an overview of programmatic advertising, its advantages for pharma marketers, strategies for precision, and challenges to consider.
PharmaTech
OCTOBER 6, 2023
The agreement will enable CTMC to strategically scale the recently completed good manufacturing practice facility to drive high-throughput manufacturing utilizing the automated, closed system capabilities of the Fresenius Kabi Lovo and Cue cell processing systems.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
PM360
OCTOBER 6, 2023
Children with rare diseases know a lot about some pretty grown-up topics. Many can tell you how doctors treat their life-altering symptoms while in pre-school. Others can recall lengthy therapy names before their first spelling test. Some can share statistics that prove just how unique they truly are while their peers are still learning to count. Arkansas Children’s , a leader in primary and specialty care, is teaming up with nonprofit Beyond the Diagnosis to make sure the beauty of chil
The Marketing Advantage
OCTOBER 6, 2023
October 6, 2023 One of the most challenging aspects of utilizing a sales compensation plan that does not have a fixed budget is that, too often, the plan ends up paying more or less than expected. While less effective sales compensation plans such as forced rank provide the ability to know the total that will be paid out in advance, more effective and equitable sales compensation plans such as goal and commission do not, which can result in such designs not being utilized or payouts under such d
Legacy MEDSearch
OCTOBER 6, 2023
Cadence, Inc., a leading provider of design, development, and contract manufacturing services to the medical device, drug delivery, and diagnostics markets, announced today that it has acquired the Florida location of ARC Group Worldwide ( arcw.com ), a precision manufacturer specializing in Metal Injection Molding (MIM) and cleanroom plastic injection molding.
Pharmacy Times
OCTOBER 6, 2023
Ketamine topical cream may alleviate symptoms of PTSD without causing the adverse effects and abuse potential often associated with other forms of ketamine administration.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
pharmaphorum
OCTOBER 6, 2023
Orchard will help Kyowa Kirin grow in gene therapy Phil.
Pharmaceutical Technology
OCTOBER 6, 2023
Biologics are poised to overtake innovative small molecules in terms of sales revenue by 2027, with forecast sales of $120bn.
pharmaphorum
OCTOBER 6, 2023
Boehringer moves obesity therapy into phase 3 Phil.
Pharmaceutical Technology
OCTOBER 6, 2023
The panel identified several issues with the trial including study organisation and loss of follow-up data from patients who withdrew consent.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Expert insights. Personalized for you.
289 
Let's personalize your content